Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …

There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …

Background Extracorporeal life support (ECLS) is increasingly used in the treatment of
infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality …

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is
increasingly being used for circulatory support in patients with cardiogenic shock, although …

Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is
increasingly used to treat cardiogenic shock. However, VA-ECMO might hamper myocardial …

Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly
used in patients with cardiogenic shock despite the lack of evidence from adequately …

Background In acute myocardial infarction complicated by cardiogenic shock the use of
mechanical circulatory support devices remains controversial and data from randomized …

The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular
microaxial flow pump that is currently used for (1) cardiogenic shock,(2) left ventricular …

BACKGROUND: Although venoarterial extracorporeal membrane oxygenation (VA-ECMO)
is beneficial for the treatment of profound cardiogenic shock, peripheral VA-ECMO …

Background Extracorporeal membrane oxygenation (ECMO) is a form of life support that
targets the heart and lungs. Extracorporeal membrane oxygenation for severe respiratory …